01 December 2008
Pharma industry attacked over patent strategies (full version)
Managing Intellectual Property
The pharmaceutical industry has rejected criticisms, made in an EU report released last week, that it uses patents to block generic competition
The pharmaceutical industry has rejected criticisms, made in an EU report released last week, that it uses patents to block generic competition
The rest of this article is available to subscribers to Managing IP only.
Subscribe today to this product for full access to this article. Alternatively, take a 48-hour free trial giving you access to the current content.
If you are already a subscriber please log in (see top right column) to access the rest of this article.
